WIX.COM LTD (WIX)
IL0011301780 - Common Stock
WIX.COM LTD
NASDAQ:WIX (6/28/2024, 7:00:03 PM)
After market: 159.71 +0.64 (+0.4%)159.07
-0.12 (-0.08%)
Company Profile
Wix.com Ltd. operates a cloud-based website design and development platform. The firm provides solutions that business owners can use to operate various aspects of their business online, such as selling goods, taking reservations, and scheduling and confirming appointments. These applications provide Wix registered users a bespoke front-end for customers visiting their Website, as well as a back-end management dashboard. The firm has developed these software applications for businesses in specific verticals, including retail and online stores, service providers, hotel and property management, music and restaurants. These vertical applications are integrated into the Company's Website templates or can be installed on any existing Website and set up by the user and without the need to write code.
Company Info
WIX.COM LTD
40 Namal
TEL AVIV-YAFO 6701101
P: 97235454900
CEO: Avishai Abrahami
Employees: 4590
Website: https://www.wix.com
WIX News
25 days ago - Wix.com LtdWix Announces Users Can Create Professional Native Mobile Applications with AI/PRNewswire/ -- Wix.com Ltd. (NASDAQ: WIX), the leading SaaS website builder platform to create, manage, and grow a global, digital presence1, today announced...
a month ago - The Motley Fool2 Reasons to Buy Shopify Stock Like There's No TomorrowIt's not very often that you can buy a potential $1 trillion business at a 90% discount.
a month ago - The Motley FoolHistory Says the Nasdaq Will Soar in 2024: Here Are My Top 5 Software Growth Stocks to Buy Right NowThe Nasdaq soared 43% last year and is already up 13% so far in 2024. More gains could be on the horizon for tech stocks.
a month ago - The Motley Fool1 Unstoppable Growth Stock Trading at a Price You May Never See AgainThis is a great time to buy shares or add to a position.
a month ago - The Motley FoolA New Name in Weight Loss DrugsNovo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.
a month ago - UsercentricsUsercentrics Partners With Wix to Launch First Consent Solution on the Wix App MarketWIX Twits
Here you can normally see the latest stock twits on WIX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
